ThalesNano and ETH Zurich Collaborate on Flow Chemistry Technologies



    BUDAPEST and ZURICH, Germany, Oct. 25 /CNW/ - ThalesNano Inc. and ETH
Zurich, ThalesNano today announced collaboration with the Swiss Federal
Institute of Technology Zurich (ETH Zurich) on flow chemistry applications.
The agreement will focus on the application of chemistries and technologies
utilizing ThalesNano's products to solve difficult chemistry applications.
    Dr. Laszlo Urge, CEO of ThalesNano Inc., said, "We are extremely pleased
to be able to collaborate with one of the top research universities in the
world. This collaboration will enable us to utilize our technology and to
jointly develop novel applications that will serve the entire scientific
community. Our products are in use at all major pharmaceutical, agrochemical
and chemistry companies and also support in-house scientists in developing
their own novel applications. The technology developed as part of this
collaboration may result in spin-off opportunities in future."
    Professor Peter Seeberger whose laboratory at ETH Zurich is leading the
project said, "We are delighted to have this collaboration with the foremost
company in flow chemistry instrument and application development. This is a
very exciting area of technology, and in it we anticipate being able to
contribute to the development of novel chemistries. There are a lot of
scientific and technical advantages in this field. We are looking forward to
the combined exploration."
    Professor Ferenc Darvas, president and chairman of ThalesNano Inc. said:
"This agreement again highlights the interest that the academic world has
shown in using our products, such as H-Cube, H-Cube Tutor and X-Cube, to
develop applications. ETH Zurich and other leading universities are proactive,
taking the lead in application development. Our work with ETH Zurich 
underscores that academic collaboration with industry is key to the full
implementation and utilization of novel technologies.
    For more information please go to: http://www.thalesnano.com

    About ThalesNano Inc.

    ThalesNano is a technology-intensive company that provides solutions for
leading pharmaceutical and biotechnology companies all over the world. It
specializes in developing and providing microscale flow instruments for
chemistry by exploiting the benefits of combining microfluidics, mezofluidics
or nanotechnology with flow chemistry. R&D Magazine recognized the award
winning development, H-Cube(TM), as one of the 100 most technologically
significant and innovative new products of 2005. H-Cube(TM) is the first in a
new wave of continuous-flow hydrogenation reactors. Utilizing water
electrolysis to generate hydrogen, a catalyst cartridge system and a
continuous-flow reactor, the shoe-box sized H-Cube(TM) makes hydrogenation
convenient, more efficient and less hazardous. X-Cube is a high-pressure,
high-temperature flow reactor. With these tools, reactions that are almost
impossible to carry out under normal circumstances can be safely performed.

    About ETH Zurich

    ETH Zurich (Swiss Federal Institute of Technology) has a student body of
over 13,000 students from 80 nations. Nearly 360 professors teach mainly in
engineering sciences and architecture, system-oriented sciences, mathematics
and natural sciences, as well as carry out research that is highly valued
worldwide. Distinguished by the successes of 21 Nobel laureates, ETH Zurich is
committed to providing its students with unparalleled education and
outstanding leadership skills.





For further information:

For further information: Dr. Laszlo Urge, CEO, Tel: +36-1-8808-500, or
send an email to info@thalesnano.com

Organization Profile

THALESNANO INC.

More on this organization

ETH ZURICH

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890